Lastly, it is challenging to harmonize the assays to assess PD-L1 expression in tumor tissues, including how to select an appropriate PD-L1 assay platform and how to score the PD-L1 expression consistently and accurately on tumor cells, immune cells, or both [32,33,34]. The gene discussed is CD274; the disease is neoplasm.